Company Filing History:
Years Active: 1999
Title: The Innovations of Inventor Rene Bruegger
Introduction: Rene Bruegger is an accomplished inventor based in Berne, Switzerland. With a focus on developing advanced medical solutions, he has made significant contributions to the field of immunology. His innovative approaches have led to valuable advancements in the formulation of immunoglobulins.
Latest Patents: Rene Bruegger holds a notable patent for "Liquid Immunoglobulin Formulations." This patent details immunoglobulin preparations, specifically liquid formulations of immunoglobulin G intended for intravenous infusion. These formulations are stabilized against dimer formation through the incorporation of various amphiphilic stabilizers. Among the preferred stabilizers are nicotinic acid derivatives, particularly nicotinamide, alongside naturally occurring α-amino acids possessing a lipophilic side chain, such as phenylalanine, proline, leucine, and isoleucine.
Career Highlights: Throughout his career, Rene has been dedicated to advancing medical research and therapies. His work has placed him at the forefront of innovations in blood transfusion and immune therapies, reflecting a commitment to patient care and scientific excellence.
Collaborations: At the Red Cross Foundation Central Laboratory Blood Transfusion Service, Rene collaborates with talented colleagues, including Katharina Gennari and Gerhard Hodler. Together, they enhance research initiatives aimed at improving blood products and therapeutic solutions.
Conclusion: Rene Bruegger's contributions to the field of immunology demonstrate the vital role of innovation in healthcare. With a focus on liquid immunoglobulin formulations, he continues to push the boundaries of medical science, ensuring improved outcomes for patients worldwide. His collaborative efforts further amplify the impact of his work, reflecting a strong commitment to advancing healthcare through innovation.